The pathophysiology and clinical presentation of cerebral amyloid angiopathy (Q38008170)

26 August 2017

The pathophysiology and clinical presentation of cerebral amyloid angiopathy (English)

1 reference

26 August 2017

1 reference

Eitan Auriel

1

1 reference

PubMed ID

22565298

26 August 2017

Steven Mark Greenberg

series ordinal

2

1 reference

26 August 2017

1 August 2012

1 reference

Current Atherosclerosis Reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

4

1 reference

26 August 2017

343-350

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-012-0254-z

26 August 2017

0 references

cites work

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebrovascular lesions induce transient β-amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Alzheimer's disease: genetic studies and transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Microbleeds versus macrobleeds: evidence for distinct entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Clinical phenotypes of Cerebral Amyloid Angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Brain parenchymal and microvascular amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy as cause of convexity SAH in elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cortical subarachnoid haemorrhage in the elderly: a recurrent event probably related to cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Superficial siderosis in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Impaired visual evoked flow velocity response in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral microbleeds and vascular cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Cerebral amyloid angiopathy pathology and cognitive domains in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

A stop-codon mutation in the BRI gene associated with familial British dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

The cerebral beta-amyloid angiopathies: hereditary and sporadic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Course of cerebral amyloid angiopathy-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Lobar Distribution of Cerebral Microbleeds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0254-Z

Anti-A autoantibodies in the CSF of a patient with CAA-related inflammation: A case report

21 January 2018

1 reference

12 December 2020

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease

1 reference

12 December 2020

The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage

1 reference

12 December 2020

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

1 reference

12 December 2020

A review of light, polarization and fluorescence microscopic methods for amyloid

1 reference

12 December 2020

High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice

1 reference

12 December 2020

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria

1 reference

12 December 2020

Subarachnoid Hemosiderosis and Superficial Cortical Hemosiderosis in Cerebral Amyloid Angiopathy

1 reference

12 December 2020

High frequency of apolipoprotein E ?2 Allele in hemorrhage due to cerebral amyloid angiopathy

1 reference

12 December 2020

Clinicopathologic studies of primary cerebral amyloid angiopathy.

1 reference

12 December 2020

Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy

1 reference

12 December 2020

Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

1 reference

12 December 2020

Spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Cerebral amyloid angiopathy: the vascular pathology and complications.

1 reference

12 December 2020

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy

1 reference

12 December 2020

10.1007/S11883-012-0254-Z

Identifiers

DOI

1 reference

PubMed ID

22565298

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22565298